Creatine target engagement with brain bioenergetics: a dose-ranging phosphorus-31 magnetic resonance spectroscopy study of adolescent females with SSRI-resistant depression
Open accessThe DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Abstract
Major depressive disorder (MDD) often begins during adolescence and is projected to become the leading cause of global disease burden by the year 2030. Yet, approximately 40 % of depressed adolescents fail to respond to standard antidepressant treatment with a selective serotonin reuptake inhibitor (SSRI). Converging evidence suggests that depression is related to brain mitochondrial dysfunction. Our previous studies of MDD in adult and adolescent females suggest that augmentation of SSRI pharmacotherapy with creatine monohydrate (CM) may improve MDD outcomes. Neuroimaging with phosphorus-31 magnetic resonance spectroscopy ((31)P-MRS) can measure the high-energy phosphorus metabolites in vivo that reflect mitochondrial function. These include phosphocreatine (PCr), a substrate for the creatine kinase reaction that produces adenosine triphosphate. As part of the National Institute of Mental Health's experimental medicine initiative, we conducted a placebo-controlled dose-ranging study of adjunctive CM for adolescent females with SSRI-resistant MDD. Participants were randomized to receive placebo or CM 2, 4 or 10 g daily for 8 weeks. Pre- and post-treatment (31)P-MRS scans were used to measure frontal lobe PCr, to assess CM's target engagement with cerebral energy metabolism. Mean frontal lobe PCr increased by 4.6, 4.1 and 9.1 % in the 2, 4 and 10 g groups, respectively; in the placebo group, PCr fell by 0.7 %. There was no group difference in adverse events, weight gain or serum creatinine. Regression analysis of PCr and depression scores across the entire sample showed that frontal lobe PCr was inversely correlated with depression scores (p = 0.02). These results suggest that CM achieves target engagement with brain bioenergetics and that the target is correlated with a clinical signal. Further study of CM as a treatment for adolescent females with SSRI-resistant MDD is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“When combined with regular antidepressant use, 8-weeks of CrM supplementation reduced depressive symptoms in female adolescents and adults with major depression [86,87,88].”
From Creatine supplementation in women's health: a lifespan perspective (2021) · cites this paper as [87]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The increase in cerebral PCr from 10 g of creatine supplementation was reported to be inversely related to symptoms of depression in adolescent females resistant to selective serotonin reuptake inhibitors [171]”
From Common questions and misconceptions about creatine supplementation: what does the scientific evidence really show? (2021) · cites this paper as [171]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Reports since the early 1980s have suggested that creatine metabolism and/or availability may have antidepressive effects [312,313,314,315,316,317,318].”
From Creatine in health and disease (2021) · cites this paper as [317]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Creatine monohydrate dosing protocols varied across studies. Weight-based regimens included approximately 0.1 g/kg/day, while fixed daily dosing ranged from 2 to 10 g/day. Several trials employed loading-maintenance strategies consisting of short loading phases (e.g., 20 g/day) followed by maintenance dosing (e.g., 5 g/day) [12-14].”
From Evaluating the Safety of Creatine Monohydrate in Adolescents: A Systematic Review of Renal, Hepatic, and Cardiometabolic Outcomes (2026) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Across randomized controlled trials in pediatric and adolescent populations, no clinically meaningful changes were observed in serum creatinine, estimated glomerular filtration rate (eGFR), or other renal biomarkers [12-14].”
From Evaluating the Safety of Creatine Monohydrate in Adolescents: A Systematic Review of Renal, Hepatic, and Cardiometabolic Outcomes (2026) · cites this paper as [12]
Experimental — accuracy not yet measured
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A heteroskedasticity-consistent covariance matrix estimator and a direct test for heteroskedasticity
White, H. (1980) · Econometrica · doi:10.2307/1912934 · Cited by 25,861
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962 · cited 3×
“…Rating Scale-Revised (CDRS-R) (Poznanski and Mokros 1996; Mayes et al. 2010) raw score of >40 or Montgomery–Asberg Depression Rating Scale (MADRS) (Montgomery and Asberg 1979) score >25; and current Clinical Global Impression Scale-Severity (CGI-S) (Guy 1976) score ≥4, indicating moderate…”
KAUFMAN, J., BIRMAHER, B., BRENT, D., RAO, U., FLYNN, C., MORECI, P., WILLIAMSON, D., & RYAN, N. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199707000-00021 · Cited by 10,148
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Merikangas, K. R., He, J.-P., Burstein, M., Swanson, S. A., Avenevoli, S., Cui, L., Benjet, C., Georgiades, K., & Swendsen, J. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.05.017 · Cited by 6,278 · cited 4×
“1991); in fact, MDD has a cumulative prevalence of 15–24 % by age 19 (Lewinsohn et al. 1998; Merikangas et al. 2010) and results in significant disability and mortality in this age group (Birmaher et al.”
InfluentialFerrari, A. J., Charlson, F. J., Norman, R. E., Patten, S. B., Freedman, G., Murray, C. J. L., Vos, T., & Whiteford, H. A. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001547 · Cited by 3,115
Psychiatric disorders in America: the epidemiologic catchment area study
(1991) · Choice Reviews Online · doi:10.5860/choice.28-5931 · Cited by 2,555
Hankin, B. L., Abramson, L. Y., Moffitt, T. E., Silva, P. A., McGee, R., & Angell, K. E. (1998) · Journal of Abnormal Psychology · doi:10.1037/0021-843x.107.1.128 · Cited by 2,333
Wallimann, T., Wyss, M., Brdiczka, D., Nicolay, K., & Eppenberger, H. M. (1992) · Biochemical Journal · doi:10.1042/bj2810021 · Cited by 2,011
Research works printed but not linked: 3
- First MB Williams JB Spitzer RL Gibbon M Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Clinical Trials Version (SCID-CT) 2007 Biometrics Research, New York State Psychiatric Institute New York
- Huber PJ Lecam L Neyman J The behavior of maximum likelihood estimates under nonstandard conditions 1967 1 221 233 Proceedings of the fifth Berkeley symposium on mathematical statistics and probability. Volume 1: theory of statistics University of California Press Berkeley and Los Angeles, CA USA
- Poznanski EO Mokros HB Children’s Depression Rating Scale, Revised (CDRS-R) manual 1996 Western Psychological Services Los Angeles
Cited by
Antonio, J., Candow, D. G., Forbes, S. C., Gualano, B., Jagim, A. R., Kreider, R. B., Rawson, E. S., Smith-Ryan, A. E., VanDusseldorp, T. A., Willoughby, D. S., et al. (2021) · Journal of the International Society of Sports Nutrition · doi:10.1186/s12970-021-00412-w · Cited by 345
“The increase in cerebral PCr from 10 g of creatine supplementation was reported to be inversely related to symptoms of depression in adolescent females resistant to selective serotonin reuptake inhibitors [171] It appears that creatine supplementation may be Antonio et al.”
BackgroundCreatine in health and disease
Kreider, R. B., & Stout, J. R. (2021) · Nutrients · doi:10.3390/nu13020447 · Cited by 227
Dolan, E., Gualano, B., & Rawson, E. S. (2019) · European Journal of Sport Science · doi:10.1080/17461391.2018.1500644 · Cited by 171
Living High and Feeling Low: Altitude, Suicide, and Depression
Kious, B. M., Kondo, D. G., & Renshaw, P. F. (2018) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000158 · Cited by 145
Self-citationMagnetic Resonance Spectroscopy and its Clinical Applications: A Review
Faghihi, R., Zeinali-Rafsanjani, B., Mosleh‐Shirazi, M. A., Saeedi-Moghadam, M., Lotfi, M., Jalli, R., & Iravani, V. (2017) · Journal of medical imaging and radiation sciences · doi:10.1016/j.jmir.2017.06.004 · Cited by 106
Creatine supplementation in women's health: a lifespan perspective
Smith-Ryan, A. E., Cabre, H. E., Eckerson, J. M., & Candow, D. G. (2021) · Nutrients · doi:10.3390/nu13030877 · Cited by 92
Balestrino, M., & Adriano, E. (2019) · Medicinal Research Reviews · doi:10.1002/med.21590 · Cited by 90
“A randomized, placebo‐controlled study on 34 adolescent females with major depressive disorder resistant to traditional antidepressant therapy with SSRI has been reported.(137) Participants were administered either placebo or creatine (2, 4, or 10 g/d) for 8 weeks in addition to the already ongoing therapy.”
MethodDietary creatine intake and depression risk among U.S. adults
Bakian, A. V., Huber, R. S., Scholl, L., Renshaw, P. F., & Kondo, D. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-0741-x · Cited by 90
Self-citationAltitude and risk of depression and anxiety: findings from the intern health study
Kious, B. M., Bakian, A. V., Zhao, J. L., Mickey, B. J., Guille, C., Renshaw, P. F., & Sen, S. (2019) · International Review of Psychiatry · doi:10.1080/09540261.2019.1586324 · Cited by 89
Self-citationWallimann, T., Riek, U., & Möddel, M. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2016.12.002 · Cited by 87
The Brain at High Altitude: From Molecular Signaling to Cognitive Performance
Aboouf, M. A., Thiersch, M., Soliz, J., Gassmann, M., & Gasser, E. M. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210179 · Cited by 84
“Heads up” for creatine supplementation and its potential applications for brain health and function
Candow, D. G., Forbes, S. C., Ostojic, S. M., Prokopidis, K., Stock, M. S., Harmon, K. K., & Faulkner, P. (2023) · Sports Medicine · doi:10.1007/s40279-023-01870-9 · Cited by 78
Creatine for the Treatment of Depression
Kious, B. M., Kondo, D. G., & Renshaw, P. F. (2019) · Biomolecules · doi:10.3390/biom9090406 · Cited by 74
“Kondo 2016 [170] Adolescent and young-adult women with MDD-D (n = 34) Open-label, adjunctive, dose-ranging 2 g, 4 g, or 10 g/day 8 weeks Creatine increased frontal cortical phosphocreatine levels in a fashion associated with lower depression ratings None”
InfluentialSelf-citationBrain choline in major depression: A review of the literature
Riley, C., & Renshaw, P. F. (2017) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2017.11.009 · Cited by 73
Self-citationLi, H., Xu, H., Zhang, Y., Guan, J., Zhang, J., Xu, C., Shen, Z., Xiao, B., Liang, C., Chen, K., et al. (2016) · Bipolar Disorders · doi:10.1111/bdi.12445 · Cited by 64
Rathour, D., Shah, S., Khan, S., Singh, P. K., Srivastava, S., Singh, S. B., & Khatri, D. K. (2022) · Behavioural Brain Research · doi:10.1016/j.bbr.2022.114081 · Cited by 61
Marshall, R. P., Droste, J.-N., Gießing, J., & Kreider, R. B. (2022) · Nutrients · doi:10.3390/nu14030529 · Cited by 57
Döme, P., Tombor, L., Lazáry, J., Gonda, X., & Rihmer, Z. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.12.015 · Cited by 54
Toniolo, R. A., Silva, M., Fernandes, F. D. B. F., Amaral, J. A. D. M. S., Dias, R. D. S., & Lafer, B. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-017-1817-5 · Cited by 50
Wallimann, T., Hall, C., Colgan, S., & Glover, L. (2021) · Nutrients · doi:10.3390/nu13051429 · Cited by 47
Güleş, E., Iosifescu, D. V., & Tural, Ü. (2020) · Neuropsychobiology · doi:10.1159/000505782 · Cited by 42
The possible beneficial effects of creatine for the management of depression
Pazini, F. L., Cunha, M. P., & Rodrigues, A. L. S. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.08.029 · Cited by 40
Creatine: a miserable life without it
Wallimann, T., & Harris, R. C. (2016) · Amino Acids · doi:10.1007/s00726-016-2297-x · Cited by 38
de Guingand, D. L., Palmer, K. R., Snow, R. J., Davies-Tuck, M. L., & Ellery, S. J. (2020) · Nutrients · doi:10.3390/nu12061780 · Cited by 35
“16) [33] and the last reported solely on change in serum creatinine levels for the purpose of assessing treatment compliance [35].”
BackgroundMethodWu, W., Howard, D., Sibille, E. L., & French, L. (2021) · Translational Psychiatry · doi:10.1038/s41398-020-01127-3 · Cited by 33
Primary outcome reporting in adolescent depression clinical trials needs standardization
Monsour, A., Mew, E. J., Patel, S., Chee-A-Tow, A., Saeed, L., Santos, L., Courtney, D., Watson, P., Monga, S., Szatmári, P., et al. (2020) · BMC Medical Research Methodology · doi:10.1186/s12874-020-01019-6 · Cited by 33
Creatine as a Therapeutic Target in Alzheimer's Disease
Smith, A. N., Morris, J. K., Carbuhn, A. F., Herda, T. J., Keller, J. E., Sullivan, D. K., & Taylor, M. K. (2023) · Current Developments in Nutrition · doi:10.1016/j.cdnut.2023.102011 · Cited by 33
Persson, J., Wall, A. E., Weis, J., Gingnell, M., Antoni, G., Lubberink, M., & Bodén, R. (2021) · Psychiatry Research Neuroimaging · doi:10.1016/j.pscychresns.2021.111327 · Cited by 31
Juneja, K., Bhuchakra, H. P., Sadhukhan, S., Mehta, I., Niharika, A., Thareja, S., Nimmakayala, T., & Sahu, S. (2024) · Cureus · doi:10.7759/cureus.71638 · Cited by 30
Kanekar, S., Ettaro, R., Hoffman, M. D., Ombach, H. J., Brown, J., Lynch, C. J., Sheth, C. S., & Renshaw, P. F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158195 · Cited by 30
Self-citationKahl, K. G., Atalay, S., Maudsley, A. A., Sheriff, S., Cummings, A., Frieling, H., Schmitz, B., Lanfermann, H., & Ding, X.-Q. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109916 · Cited by 29
Novel Targets for Fast Antidepressant Responses: Possible Role of Endogenous Neuromodulators
Camargo, A., & Rodrigues, A. L. S. (2019) · Chronic Stress · doi:10.1177/2470547019858083 · Cited by 28
Kious, B. M., Sabic, H., Sung, Y.-H., Kondo, D. G., & Renshaw, P. (2017) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000754 · Cited by 27
Self-citationRelationship between depression, prefrontal creatine and grey matter volume
Faulkner, P., Paioni, S. L., Kozhuharova, P., Orlov, N., Lythgoe, D. J., Daniju, Y., Morgenroth, E., Barker, H., & Allen, P. (2021) · Journal of Psychopharmacology · doi:10.1177/02698811211050550 · Cited by 27
Cunha, M. P., Pazini, F. L., Lieberknecht, V., & Rodrigues, A. L. S. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.07.001 · Cited by 25
Sherpa, N. N., De Giorgi, R., Ostinelli, E. G., Choudhury, A., Dolma, T., & Dorjee, S. (2025) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2024.10.004 · Cited by 22
Ramos‐Jiménez, A., Rubio-Valles, M., Ramos-Hernández, J. A., González-Rodríguez, E., & Moreno-Brito, V. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178697 · Cited by 21
White, T. L., Gonsalves, M. A., Cohen, R. A., Harris, A. D., Monnig, M. A., Walsh, E. G., Nitenson, A. Z., Porges, E. C., Lamb, D. G., Woods, A. J., et al. (2020) · NeuroImage · doi:10.1016/j.neuroimage.2020.117509 · Cited by 19
Low Tissue Creatine: A Therapeutic Target in Clinical Nutrition
Ostojić, S. M. (2022) · Nutrients · doi:10.3390/nu14061230 · Cited by 19
Kim, E., Park, S., Kim, S.-J., Choi, Y., Cho, J. H., & Kim, G. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2022.1021618 · Cited by 18
Functional MRI markers for treatment-resistant depression: Insights and challenges
Kotoula, V., Evans, J. W., Punturieri, C., Johnson, S. C., & Zarate, C. A. (2023) · Progress in brain research · doi:10.1016/bs.pbr.2023.04.001 · Cited by 19
Does one dose of creatine supplementation fit all?
Candow, D. G., Ostojic, S. M., Forbes, S. C., & Antonio, J. (2024) · Advanced Exercise and Health Science · doi:10.1016/j.aehs.2024.05.002 · Cited by 16
Impaired Bioenergetics in Clinical Medicine: A Target to Tackle
Ostojić, S. M. (2017) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.243.227 · Cited by 12
Creatine Monohydrate Supplementation: Considerations for Cognitive Performance in Athletes
Machek, S. B., & Bagley, J. R. (2018) · Strength and conditioning journal · doi:10.1519/ssc.0000000000000369 · Cited by 11
Feng, X., Yang, C., Yang, H.-J., Wang, K., Xu, Y., Zhang, X., Zhang, Q., & Ma, J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1018391 · Cited by 10
Zhu, Z., Cheng, Y., Han, X., Wang, T., Zhang, H., Yao, Q. Z., Chen, F., Gu, L., Yang, D., Chen, L., et al. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c00415 · Cited by 10
The emerging and evolving evidence supporting creatine as an ergogenic aid: history and applications
Kerksick, C. M., Gonzalez, D. E., Stout, J. R., Forbes, S., Candow, D. G., Ziegenfuss, T. N., Marshall, R. P., Schwesig, R., & Kreider, R. B. (2026) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2026.2646627 · Cited by 9
Zhou, H., Gao, Y., Dong, T., Wang, J., & Liu, Z. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119747 · Cited by 9
Creatine Supplementation: More Is Likely Better for Brain Bioenergetics, Health and Function
Fabiano, N., & Candow, D. (2025) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20250006 · Cited by 9
Fares, B. J., Zhou, C., Fabiano, N., Wong, S., Stubbs, B., Shorr, R., Puder, D., Candow, D. G., Ostojić, S. M., & Solmi, M. (2026) · The Canadian Journal of Psychiatry · doi:10.1177/07067437251408171 · Cited by 8
Gonzalez, D. E., Forbes, S. C., Zapp, A., Jagim, A. R., Luedke, J. A., Dickerson, B. L., Root, A., Gil, A. C., Johnson, S. E., Coles, M. E., et al. (2024) · Nutrients · doi:10.3390/nu16193285 · Cited by 9
Pratt, J., Fuchs, C. J., van Loon, L. J. C., Kennerley, A. J., & Sale, C. (2026) · The Journal of Nutritional Physiology · doi:10.1016/j.jnphys.2026.100017 · Cited by 6
The role of brain creatine in behavioral health conditions
Han, E. S., Yancey, J. R., Yurgelun-Todd, D. A., Kondo, D. G., Boxer, D., & Renshaw, P. F. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1667639 · Cited by 6
Self-citationCreatine Supplementation and the Brain: Have We Put the Cart Before the Horse?
Candow, D. G., Pratt, J., Fabiano, N., Gordji-Nejad, A., Smith, A., Rawson, E. S., Moriarty, T. A., Forbes, S. C., & Kerksick, C. M. (2026) · Journal of Dietary Supplements · doi:10.1080/19390211.2026.2616440 · Cited by 6
Creatine supplementation for treating symptoms of depression: a systematic review and meta-analysis
Eckert, I. D. C., Lima, J., & Dariva, A. A. (2025) · British Journal Of Nutrition · doi:10.1017/s0007114525105588 · Cited by 6
New Somatic Treatments for Child and Adolescent Depression
Cullen, K. R., Padilla, L. E., Papke, V. N., & Klimes-Dougan, B. (2019) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-019-00194-8 · Cited by 5
A guide to what works for depression: An evidence-based review
Morgan, A. J., Reavley, N. J., Jorm, A. F., Bassilios, B., Hopwood, M., Allen, N. B., & Purcell, R. (2019) · Cited by 5
Squarcina, L., Delvecchio, G., Nobile, M., Mauri, M., Madonna, D., Bonivento, C., Garzitto, M., Piccin, S., Molteni, M., Tomasino, B., et al. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00763 · Cited by 5
Wang, Y., Li, J., Zhu, L. L., Wu, Y., Su, Y. G., & Si, T. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03732-y · Cited by 4
The significance of dysregulated serine metabolism in depression
Lu, Y., Lv, M., Zhao, C., Pei, J., & Zhou, M. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118458 · Cited by 3
Integrative Interventions for Improving Outcomes in Depression: A Narrative Review
Halma, M. T. J., Plothe, C., & Marik, P. E. (2024) · Psychology International · doi:10.3390/psycholint6020033 · Cited by 2
Toniolo, R. A. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-07122016-150647 · Cited by 2
Suplementación con creatina y cerebro: una revisión narrativa que merece ser valorada
Vargas, J. J. N., & Espinoza, M. A. R. (2022) · Revista de Investigación de la Universidad Norbert Wiener · doi:10.37768/unw.rinv.11.01.r0002 · Cited by 2
Chun, J., Babakhani, K., Gonzalez, D. E., Dickerson, B. L., Sowinski, R. J., Rasmussen, C. J., & Kreider, R. B. (2026) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2026.2711032 · Cited by 2
Applications of Neuroimaging Biomarkers in CNS Drug Development
Cole, P. E., & Einstein, S. G. (2019) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-12-803161-2.00009-6 · Cited by 2
Creatine in neuroprotection and neurotoxicity
Kanekar, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23763-8.00058-0 · Cited by 2
Neuroimaging as a Tool for Advancing Pediatric Psychopharmacology
Bartkoski, M., Tumberger, J., Martin, L. E., Choi, I., Lee, P., Strawn, J. R., Brooks, W. M., & Stancil, S. L. (2025) · Pediatric Drugs · doi:10.1007/s40272-025-00683-9 · Cited by 2
Farfán-Díaz, Á., Fuentes-Hinojosa, C., Andrade-Oyarzun, M., Garcia-Carrillo, E., Molina-Márquez, I., Yáñez-Sepúlveda, R., Castillo-Paredes, A., Barrera-González, D., & Montalva-Valenzuela, F. (2026) · Adolescents · doi:10.3390/adolescents6040059 · Cited by 1
“In adolescent females with selective serotonin reuptake inhibitor (SSRI)-resistant depression, an 8-week placebo-controlled dose-ranging trial (2, 4, or 10 g/day) demonstrated brain PCr target engagement without a between-group signal in adverse events, weight gain, or serum creatinine [72].”
Creatine and the plurality of its uses, with emphasis on its supplementation in sports
Minkner, M., Petryla, P., Ostafin, K., Edyko, K., Suwała, Z., Feja, K., Bieńkowski, B., Marchewka, U., Łuczak, E., & REKTOR, N. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.46.01.007 · Cited by 1
THE ROLE OF CREATINE IN NEUROLOGICAL DISORDERS: A LITERATURE REVIEW
Omidi, A., Ćwiek, M., Malec, K., Krawiec, B., Zarębski, B., Jadanowski, O., Sójka, J., Szombara, M., Mokrzyński, M., & Szyszka, P. (2025) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.3(47).2025.3722 · Cited by 1
Valchinkova, I., & Kostadinova, I. (2026) · Pharmacia · doi:10.3897/pharmacia.73.e201921 · Cited by 1
Zimowski, M., Panas, Z., Ślinko, I., Kuliś, G., Dryl-Jarmoc, E., Krawczuk, K., Dziemiańczuk, J., Kadysz, P., Kolanek, A., & Czajkowski, M. (2026) · Quality in Sport · doi:10.12775/qs.2026.55.71160 · Cited by 1
Furtak, K., Romańczuk, K. B., Krupa, O., Rybak, D., Kamińska-Omasta, K., Omasta, B., Czerska, M. A., Pietrukaniec, P. D., Stolarczyk, S. P., & Wójcik, Z. M. (2025) · Quality in Sport · doi:10.12775/qs.2025.37.57724 · Cited by 1
Rubinchuk, A., Dulkoski, Z., Persaud, N. A., & Wallen, M. (2026) · Cureus · doi:10.7759/cureus.106808
“Randomized trials in pediatric and adolescent populations reported no significant differences in adverse events or laboratory abnormalities between creatine and placebo groups [12-14].”
InfluentialChun, J., Liu, Y., Kibler, G. L., Lee, H., Babakhani, K., Rhoades, N., Bivins, I., Ko, J., Dickerson, B., Gonzalez, D. E., et al. (2026) · Journal of the International Society of Sports Nutrition · doi:10.1080/15502783.2026.2716273
Upadhyay, D., Rawat, V., Hans, G., Pandey, S., Sharan, P., & Sharma, U. (2026) · Magnetic Resonance Imaging · doi:10.1016/j.mri.2026.110797
Creatine supplementation for brain metabolic stress: a narrative review
Candow, D. G., Moriarty, T. A., Wong, S., Fabiano, N., Forbes, S. C., & Kerksick, C. M. (2026) · Academia Neuroscience and Brain Research · doi:10.20935/acadneurosci8345
Creatine monohydrate and neuronal methylation in psychiatric disorders
Strydom, L., & Xulu, K. R. (2026) · Academia Neuroscience and Brain Research · doi:10.20935/acadneurosci8396
Tan, C., Qiao, M., Ma, Y., Wang, X., Xing, M., Sun, S., Shi, Y., Wang, Y., Fang, J., & Yongsheng, Y. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1820578
Chapter 9. Pharmacotherapy for Pediatric Depression
Kim, G.-M., Gandhi, R., & Cullen, K. R. (2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615379200.lg09
Neurobiological foundations of psychosomatic disorders
Klyushnik, T., Omel'chenko, M., & Samushiya, M. A. (2026) · Современная терапия в психиатрии и неврологии · doi:10.32416/2304-9707-2026-2-22-27
Zhao, Y., Zhao, J., Xie, C., Yang, X., & 李建英 (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1931736
Myślicka, W., Veyeunik, V., Chrobak, A., Kacynel, E., Zhukava, L., Volkava, D., Sakovich, V., Alansi, A., Weng, K.-C., Bessmylna, K., et al. (2026) · Quality in Sport · doi:10.12775/qs.2026.62.73295
Szczuciński, W., Polczyk, J. K., Ogorzałek, F. M., Drelich, K., Deptuch, W., Maćko, P. K., Golińska, Z., Zając, M. T., Rajzer, P., & Rurkowska, J. (2026) · Quality in Sport · doi:10.12775/qs.2026.70.74583
Efectos neuropsiquiátricos de la creatina: ¿Qué concluye la evidencia preclínica y clínica?
Abarca, M., González, A., Dosal, I., de Leon, I., & Arancibia, M. (2026) · Revista médica de Chile · doi:10.4067/s0034-98872026000300430
The effect of creatine monohydrate supplementation dose on tissue creatine uptake in rats
Dunham, T. C. (2020) · Brock University Digital Repository (Brock University)
Cunha, M. P., Akhtar, A. S., & Ramos-Hryb, A. B. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48111174
Messina, D. N., Capone, L. A., & Río, J. A. (2024) · Investigación Ciencia y Universidad · doi:10.59872/icu.v7i8.476
Squarcina, L., Delvecchio, G., Nobile, M., Mauri, M., Madonna, D., Bonivento, C., Garzitto, M., Piccin, S., Molteni, M., Tomasino, B., et al. (2020) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00907
Condeço, M. G. G. D. S. (2020) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Feng, X., Yang, C., Yang, H., Wang, K., Xu, Y., Zhang, X., Zhang, Q., & Ma, J. (2023) · doi:10.3389/fpsyt.2022.1018391.s001
Ramalho, G. O., Pagliarini, B. C. D., Viscardi, J. B., Vitor, K., Martins, B. R., Guedes, L. C. B. D. O., Nogueira, H. C., Takahama, L. H., Dantas, A. J. D. R., da Silva, E. F. F., et al. (2025) · Journal of Medical and Biosciences Research. · doi:10.70164/jmbr.v2i4.773
Boeira, M. F., Campos, L. D. A., & Matos, L. A. C. (2026) · Revista Tópicos · doi:10.70773/revistatopicos/793324705
Metadata
- Authors
- Kondo, D. G., Forrest, L. N., Shi, X., Sung, Y.-H., Hellem, T. L., Huber, R. S., & Renshaw, P. F.
- Affiliations
- University of Utah (US)
- Corresponding author
- Kondo, Douglas G.
- ORCID
- Venue
- Amino Acids
- Published
- 2016-02-23
- Volume
- 48
- Issue
- 8
- Pages
- 1941-1954
- ISSN
- 0939-4451 (ISSN-L)
- 1438-2199
- PMC
- PMC4974294
- OpenAlex
- W2284689049
- Cited by
- 79
- References
- 98
- Citations by year
- 2026: 16 · 2025: 7 · 2024: 7 · 2023: 6 · 2022: 5 · 2021: 8 · 2020: 7 · 2019: 8 · 2018: 6 · 2017: 5 · 2016: 4
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Amino Acids (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (5R21MH096858)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Keywords
- creatine monohydrate, major depressive disorder, adolescent girls, phosphocreatine, brain bioenergetics, mitochondrial dysfunction, phosphorus-31 magnetic resonance spectroscopy, antidepressant augmentation, frontal lobe, target engagement, dose-ranging
- MeSH terms
- Adolescent, Adult, Brain, Creatinine, Major Depressive Disorder, Drug Resistance, Energy Metabolism, Female, Humans, Selective Serotonin Reuptake Inhibitors, Neuroimaging
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.